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Tuesday, February 28, 2012 555aassociated with severe cardiac hypertrophy. We observed a heart weight to
body weight ratio of 4.450.1, 4.950.1, 8.950.3 and 12.551.0 mg/g in
WT, TGSER, TGCSQ and TGCxS, respectively (n=7, P<0.05). Stained tissue
sections revealed an enhanced interstitial fibrosis in ventricles of both TGCSQ
and TGCxS. Functional analysis was performed on isolated working heart prep-
arations. Contractility (þdP/dt) was depressed in TGCxS (13785144 mmHg/s)
compared to WT, TGSER and TGCSQ (24615119, 36445161 and 18795105
mmHg/s, respectively, n=6, P<0.05). We conclude that the additional overex-
pression of SERCA2a failed to rescue the impaired cardiac phenotype of CSQ
transgenic mice.
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HRC is a high capacity Ca2þ binding protein located in the lumen of sarcoplas-
mic reticulum (SR). Previously, we had shown that HRC knock-down not only
led to enhanced Ca2þ release and Ca2þ uptake in SR, but exacerbated cardiac
function after transverse aortic constriction (TAC), suggesting its important
role in Ca2þ cycling and cardiac function. HRC-KO mice were generated
and used for the present study. Pressure overload induced by TAC in the KO
mice heart resulted in severe cardiac hypertrophy with 27% increase of heart
weight (HW) per body weight (BW) ratio and 25% increase of tibia length
per BW ratio as compared to WT TAC mice. HRC KO mice also showed de-
creased fractional shortening (FS) by 37%, increased TGF-b expression by 2
folds, severe cardiac fibrosis and highly increased number of TUNEL positive
signals in heart tissue compared to WT TAC mice. The electrocardiogram
(ECG) study showed shorter RR interval, faster heart rate and decreased R am-
plitude in HRC KO TAC mice. The incidence of arrhythmia was significantly
increased in HRC KO mice after intraperitoneal injection of caffeine (120
mg/kg BW) and epinephrine (2 mg/kg BW),indicating that HRC KO
mice are more susceptible to epinephrine and caffeine injection, consistent
with the previous report (Jaehnig et al. Mol. Cell. Biol., 2006). The survival
rate of HRC KO mice was significantly decreased after TAC. Taken together,
our results suggest that ablation of HRC could lead to altered SR Ca2þ cycling
and deterioration of cardiac function under pathological condition. (Supported
by Korea MEST NRF Grant (20110002144), the 2011 GIST System Biology
Infrastructure Establishment Grant and KISTI-KREONET).Cardiac Muscle III
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This study aimed to compare alterations in phosphorylation and function of sar-
comeric proteins in diastolic heart failure (DHF) vs. normal myocardium under
two conditions of tissue procurement: beating-heart biopsy and postmortem tis-
sue sampling. Left ventricular tissue samples were procured from normal
(CTRL) or old dogs made hypertensive by renal wrapping (DHF), by either tak-
ing biopsies of the beating heart (n=7) or excising tissue postmortem (n=8). Iso-
lated permeabilized cardiomyocytes were attached to a force transducer and
passive tension (Fpassive) was measured between 1.8 and 2.4 mm, calcium sen-
sitivity (pCa50) at 2.2 mm sarcomere length. Phosphorylation of myofilament
proteins was assessed using the SYPRO-Ruby (total protein) / Pro-Q Diamond
(phosphoprotein) system. Expression of total or phosphorylated protein, includ-
ing titin-PEVK, cTnI, and PKCa was also quantified by immunoblot. Postmor-
tem tissues and biopsy samples showed similar changes in DHF vs. CTRL,
including increased phospho-PEVK, phospho-PKCa, and Fpassive, but de-
creased titin N2BA:N2B isoform ratio and reduced phosphorylation of total ti-
tin, cMyBPC, cTnT, cTnI and cTnI (S23/24). Differences were apparent in
terms of lowered pCa50 in postmortem DHF, but increased pCa50 in biopsy
DHF. Reduced MLC2 phosphorylation in DHF vs. CTRL was observed in bi-
opsies, but not in postmortem tissues. A degradation form of titin (T2) was
more abundant in postmortem tissues than in biopsies. We conclude that this
DHF model is characterized by titin-isoform shift towards the stiff N2B iso-
form, a deficit in total titin phosphorylation, but increases in PKCa-dependent
phosphorylation of titin-PEVK-domain and cardiomyocyte Fpassive, as well as
altered pCa50. For a few parameters, postmortem and beating-heart samplesdiffered in the direction of change in DHF vs. CTRL, particularly regarding
Ca2þ-sensitivity. However, most parameters changed in the same direction,
suggesting the cellular events associated with death alter sample properties
to a modest degree.
2821-Pos Board B591
Troponin Phosphorylation Crosstalk
Benjamin R. Nixon, Sean C. Little, Elizabeth A. Brundage,
Rebecca S. Guenthardt, Jonathan P. Davis, Brandon J. Biesiadecki.
The Ohio State University, Columbus, OH, USA.
The troponin (Tn) complex is a critical regulatory and central integrative hub
for post-translational modifications (PTM) within the thin filament. There are
a number of Tn phosphorylations; however, b-adrenergic-induced protein ki-
nase A (PKA) phosphorylation of cardiac troponin I (TnI) acts as the major sar-
comeric modulator of function. Traditionally, individual phosphorylation sites
have been studied, yet simultaneous phosphorylation of multiple sites occurs in
the heart. To fully understand the molecular mechanisms underlying cardiac
muscle regulation, Tn phosphorylation must be studied as integrated events.
As an initial step towards understanding Tn crosstalk, we employed a two-
model phosphomimetic approach using cardiac human Tn. We studied AMP-
activated protein kinase (AMPK) TnI phosphorylation (TnI-S150D) and pro-
tein kinase C (PKC) cardiac troponin T (TnT) phosphorylation (TnT-T284E)
to investigate the influence of these modifications on the effects exerted by
TnI PKA phosphorylation (TnI-S23/24D). The combinatorial effects of these
phosphorylation events on TnI-S23/24D was determined by measuring tropo-
nin C calcium binding properties in the reconstituted thin filament. Calcium
dissociated from TnI-S23/24D thin filaments at 368/s compared to 103/s for
wild-type (WT). Results demonstrate that TnI-S150D alone decreases calcium
dissociation by 50%, while TnI-S150D integration with TnI-S23/24D blunted
TnI-S23/24D kinetics by 15%, demonstrating the intramolecular crosstalk of
TnI-S150D to alter the effects of TnI PKA phosphorylation. On the other
hand, TnT-T284E calcium dissociation was identical to WT, but when present
with TnI-S23/24D calcium dissociation was enhanced 136% compared to TnI-
S23/24D alone. This demonstrates an intermolecular influence of TnT phos-
phorylation on TnI PKA effects. Overall, these findings demonstrate the com-
binatorial effects of Tn site-specific phosphorylation by AMPK and PKC
crosstalk to affect the function of TnI PKA-induced phosphorylation through
both intra- and inter- molecular mechanisms. These data further highlight the
importance of understanding the role of integrated Tn PTM crosstalk on cardiac
contractile regulation.
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Male mice expressing an autosomal dominant mutation in alpha-myosin heavy
chain (R403Q) develop hypertrophic cardiomyopathy characterized by pro-
gressive left-ventricular dilation and cardiac dysfunction, whereas females do
not. We hypothesize that this sexual dimorphism exists on multiple levels, in-
cluding cellular metabolism regulation, post-translational modulation of con-
tractile proteins and mechanical functions of contractile fibers. Hearts from
wild-type (WT) and R403Q male and female animals with established disease
were analyzed for myosin heavy chain (MyHC) isoform expression, total tro-
ponin I (TnI) phosphorylation, site-specific TnI phosphorylation, AMPKa ex-
pression, and AMPK activity. Ca2þ-sensitive tension development was
measured in demembranated cardiac trabeculae. R403Q male and female
mice demonstrated progressive cardiac hypertrophy beginning at 4 months of
age. b-MyHC expression increased in male and female R403Q mice. Total
phosphorylation of TnI expression was independent of sex and R403Q muta-
tion. No difference was found in phospho-TnI-Ser22/23 in R403Q animals rel-
ative to WT controls, however R403Q females had increased expression of
phospho-TnI-Ser150 relative to WT counterparts. R403Q males showed in-
creased expression of AMPKa, however had decreased AMPK activity relative
to WT counterparts. R403Q females had reduced AMPKa expression but un-
changed AMPK activity. The R403Q mutation does not affect Ca2þ-sensitive
tension development in demembranated cardiac trabeculae from males; female
R403Q cardiac trabeculae were more sensitive to Ca2þ than WT controls. In
conclusion, R403Q mice display hypertrophy with increased expression of hy-
pertrophy marker b-MyHC. There exists a sexually dimorphic pattern of TnI
556a Tuesday, February 28, 2012phosphorylation at Ser150, although global TnI phosphorylation was un-
changed. There exists a sexually dimorphic pattern of AMPK expression and
activity, suggesting sexual dimorphic regulation of cellular metabolism and
energetics. Increased calcium sensitivity may provide sufficient contractile sup-
port in R403Q females maintaining a compensated state of cardiac function,
a characteristic not exhibited in males.
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According to the Frank-Starling relationship, greater ventricular volume in-
creases ventricular output. The Frank-Starling relationship is based partly on
the length-tension relationship in cardiac myocytes. Recently, we identified
two populations of length-tension relationships in mammalian cardiac myo-
cytes, which was dependent on PKA-induced myofibrillar phosphorylation.
We also observed a relationship between cardiac troponin I (cTnI) phosphory-
lation and steepness of ventricular function curves in rat working hearts. Thus,
we tested the hypothesis that phosphorylation of cTnI is sufficient and/or nec-
essary to control the length dependence of force generation. Our approach took
advantage of the fact that troponin can be readily exchanged in permeabilized
striated muscle cell preparations. We first used permeabilized rat slow-twitch
skeletal muscle fibers, which exhibit shallow length-tension relationships that
are unaltered by PKA. A sarcomere length-tension relationship was measured
during submaximal Ca2þ activation then the fiber was incubated in a troponin
(Tn) exchange solution, which replaced nearly all the endogenous slow Tn with
cTn. After cTn incorporation the length-tension relationship remained shallow
as predicted since the purified cTnI lacks phosphate incorporation. Next, the fi-
ber was incubated in PKA and a final sarcomere length-tension relationship
measured. Contrary to our prediction, the length-tension relationship remained
shallow after PKA phosphorylation of exogeneous cTnI. We next tested
whether cTnI phosphorylation is necessary to steepen length-tension relation-
ships in a cardiac myofibrillar background. For these experiments, we ex-
changed unphosphorylated cTn into a PKA treated myocyte that displayed
a steep length-tension relationship. In this case cTn exchange shifted the
length-tension relationship from a steep to a shallow relation. These results in-
dicate that cTnI phosphorylation is not sufficient to alter length dependence of
force generation in slow-twitch skeletal muscle fibers but appears necessary to
convert the length-tension relationship from steep to shallow in cardiac
myocytes.
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We have an engineered FRET assay in cardiac troponin (cTn) that monitors the
main structural change in troponin during activation. We performed single pair
FRET (spFRET) measurements using pulsed interleaved excitation (PIE) in the
following freely diffusing assemblies: cTn, quaternary troponin-tropomyosin
complex (TnTm), regulated thin filament (TnTnA7), and regulated thin fila-
ment in the presence of rigor cross-bridges (TnTmA7S1). 2D FRET histogram
analysis of the data reveals the populations of activated and inactivated Tn. We
report these populations under Ca2þ -free (apo) and Ca2þ -saturated (holo)
conditions.
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We have an engineered FRET assay in cardiac troponin that monitors the main
structural change in troponin during activation. We report the results of differ-
ent methods for exchanging the construct into myofibrils isolated from adult
mouse ventricular cardiomyocytes. Fluorescence lifetime imaging (FLIM) re-
vealed heterogeneous activation of troponin between the A- and I-bands in
rigor myofibrils. This suggests that strongly-bound cross bridges play a role
in the activation of the cardiac myofilament. These measurements are a precur-
sor to single pair FRET measurements of the activation of troponin within the
cardiac myofilament.2826-Pos Board B596
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We have examined various methods for introducing an engineered fluorescent
dye molecule-labeled troponin into cultured primary mouse ventricular
myocytes. The troponin complex is transported through the cell membrane
using a cell-penetrating peptide and allowed to exchange with endogenous
troponin within the myofilament. Exchange has been monitored using scanning
confocal imaging and by fluorescence lifetime imaging (FLIM). This work
may enable single pair FRET measurements of myocardial activation in
live cells.
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p21 activated kinase-1(Pak1) is a serine/threonine protein kinase functionally
linked to small and large GTPases. In the heart, Pak1 regulates activities of
ion channels and myofilament proteins through activation of phosphatase
PP2A. In mice deficient in Pak1 (Pak1-KO), ventricular hypertrophy and fibro-
sis develop in young adult (age 3-4 months). To test the hypothesis that mod-
ulation of Pak1 activity may control the progression of cardiac hypertrophy and
fibrosis, we used peptides, PRR-1, KI and Cdc42-switch I derived from Pak1
and its upstream activator Cdc42 to investigate their effects regulating activities
of angiotensin II in vivo. Angiotensin II and the peptides were infused in wt or
Pak1-KO mice through a mini-osmotic pump. Compared to those treated with
angiotensin II alone hearts from mice treated with angiotensin II plus peptides
demonstrated significantly reduced fibrosis and hypertrophy with reduced hy-
droxyproline. This inhibitory effect was absent in Pak1-KO mice. The peptide
also changes (inhibits) protein phosphorylation on signaling molecules, such as
Erk1 and SMAD3. Our studies indicate that the bioactive peptide can effi-
ciently inhibit ventricular fibrosis and hypertrophy by interacting with endog-
enous Pak1.
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In normal heart, troponin I (TnI) phosphorylation alters myofibrillar Ca2þ-sen-
sitivity and increases the speed of Ca2þ-dissociation (lusitropic effect). We
have discovered several cases in human heart muscle (DCM mutations,
HCM mutations, septal myectomy) where Ca2þ-sensitivity is independent of
TnI phosphorylation.
The ACTC E361G DCM mutation had no effect upon Ca2þ-sensitivity at all
when tested in thin filaments containing donor heart troponin. However if tro-
ponin was dephosphorylated, the wild-type actin containing thin filaments had
a higher Ca2þ-sensitivity than ACTC E361G containing thin filaments. Thus,
Ca2þ-sensitivity is uncoupled from TnI phosphorylation. This was also ob-
served with another 6 DCM mutations (TnT R141W, TnI K36Q, TnC
G159D and Tm E40K and E54K).
The ACTC E99KHCMmutation causes an increase in Ca2þ-sensitivity, but un-
coupling also occurs, as there is no difference in the Ca2þ-sensitivity of ACTC
E99K containing thin filaments with phosphorylated and dephosphorylated tro-
ponin. The uncoupling must be a direct effect of the mutation, which influences
TnI properties allosterically.
We have been studying myectomy samples as a source of human HCM tissue.
The Ca2þ-sensitivity of thin filaments with HOCM troponin was the same as
donor heart troponin even though the TnI phosphorylation levels were very dif-
ferent. This uncoupling is independent of the mutation causing HCM so one of
the troponin subunits is functionally abnormal. When HOCM troponin was ex-
changed with recombinant TnT there was a 1.9-fold higher Ca2þ-sensitivity as
was expected with the low level of phosphorylation. Therefore a change in TnT
is responsible for the observed disruption of the Ca2þ-sensitivity-phosphoryla-
tion relationship in human myectomy samples.
Thus, the ‘uncoupling’ phenomenon seems to be a widespread consequence of
cardiomyopathy and plays a key role in the pathogenesis of familial cardiomyo-
pathy.
